Immunotechnology Section, Bose Institute, P-1/12 CIT Scheme VIIM, Kolkata 700054, West Bengal, India.
J Cardiol. 2008 Oct;52(2):118-26. doi: 10.1016/j.jjcc.2008.06.005. Epub 2008 Jul 29.
Worldwide coronary heart disease (CHD) is estimated to be the leading cause of death. Current knowledge about prevention of CHD is mainly derived from developed countries. Therefore, this study aimed to find out the association of CHD with ratios of different lipoproteins and apolipoproteins, LDL particle size, as well as different traditional risk factors in Asian Indian population in Eastern part of India.
Case-control study of 100 patients with CHD and 98 healthy controls were age and sex matched. After clinical evaluation, blood samples were collected for biochemical assays.
Multivariate logistic regression analysis found apoB (OR 2.96; 95% CI 1.02-8.54), apoB/HDL-c (OR 4.14; 95% CI 1.33-12.83), nonHDL-c (OR 5.41; 95% CI 2.08-14.10), apoB/apoAI (OR 6.64; 95% CI 2.37-18.57), and LDL particle size (9.59; 95% CI 2.92-31.54) were independently associated with CHD. Area under the ROC curves derived from the model (AUROC 0.947; 95% CI 0.916-0.977) are significantly higher than any other variables.
Findings from the multivariate analysis, apoB, apoB/HDL-c, nonHDL-c, apoB/apoAI, and LDL particle size are potent indicators and useful for diagnosis of predisposed CHD.
全球范围内,冠心病(CHD)估计是首要致死原因。目前关于 CHD 的预防知识主要源自发达国家。因此,本研究旨在探究脂蛋白和载脂蛋白比值、LDL 颗粒大小以及不同传统危险因素与印度东部的印度裔人群 CHD 的相关性。
采用病例对照研究,纳入 100 例 CHD 患者和 98 例健康对照,年龄和性别相匹配。临床评估后采集血样进行生化检测。
多变量 logistic 回归分析发现载脂蛋白 B(apoB;OR 2.96;95%CI 1.02-8.54)、apoB/高密度脂蛋白胆固醇(apoB/HDL-c;OR 4.14;95%CI 1.33-12.83)、非高密度脂蛋白胆固醇(nonHDL-c;OR 5.41;95%CI 2.08-14.10)、apoB/载脂蛋白 AI(apoB/apoAI;OR 6.64;95%CI 2.37-18.57)和 LDL 颗粒大小(OR 9.59;95%CI 2.92-31.54)与 CHD 独立相关。模型得出的 ROC 曲线下面积(AUROC 0.947;95%CI 0.916-0.977)显著高于其他任何变量。
多变量分析结果显示,apoB、apoB/HDL-c、nonHDL-c、apoB/apoAI 和 LDL 颗粒大小是 CHD 易感性的有力指标,有助于 CHD 的诊断。